Jan 7 • 04:30 UTC 🇪🇸 Spain El País

The public health system spends tens of millions of euros on unnecessarily high doses of cancer therapies

Spain's public health system incurs annual expenses of tens of millions of euros on excess doses of popular cancer immunotherapies, as pharmaceutical companies persuade regulatory bodies to standardize treatment based on inflated weight assumptions.

📡 Similar Coverage